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Nanoparticle-based bioanalyte detection has been at the forefront of miniaturized systems for molecular diag-
nostics at point of care (POC) testing. In particular, gold nanoparticles (AuNPs) have been revolutionizing 
the molecular ield of optical analysis due to their good stability, visible color change between aggregate and 
non-aggregate state, and ainity with biomolecules1–4. he irst reports on molecular detection of DNA based on 
the cross-linking of AuNPs with color change5, have paved the way for several diferent approaches to circumvent 
limitations associated to current Polymerase Chain Reaction (PCR) based methods. Baptista et al. have been 
developing a non-cross-linking colorimetric method based on the diferential aggregation of oligonucleotide 
functionalized AuNPs, and hence applied it to the detection of DNA (pathogens, human genomic, etc.). More 
interestingly, this system has also been used for the detection of RNA since it enables screening and character-
ization of transcripts, allowing gene expression studies and genetic disease studies6,7. Several of these systems 
have been further incorporated into microluidics platforms for enhanced detection capabilities8–13. Microluidic 
technology provides the means for miniaturization of chemical and biochemical analysis that may easily be 
made portable14–16. hey bring several advantages when compared to standard apparatus, such as the signiicant 
decrease in volumes of reagents and samples, faster operation and reaction times, decreased analysis time and 
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decreased costs17–19. hese characteristics can be synergistically and simultaneously combined on microluidic 
platforms20,21, making microluidic devices promising for research purposes22, for high value applications in the 
medical and pharmaceutical industries23, and ideal for POC24. Optics is an efective mean of transduction that 
can be synergistically paired with microluidics to design highly compact and integrated devices25. Recent works, 
which use diferent types of nanoparticles to either provide26 or enhance27 optical output signals, have reported 
signiicant progress towards POC applications. Lately, microluidics has also burgeoned into paper-based biosen-
sors28, as they provide extremely cheap cellulosic material, compatible with many chemical/ biochemical/ medical 
applications and allow the transportation of liquids without external forces due to capillary forces29,30. However, 
this technology still faces some limitations31, such as the sample retention within channels and sample evapora-
tion during transport, which result in low eiciency of sample-delivery inside the device (usually less than 50%). 
he limit of detection (LOD) on paper microluidics is also poorer when compared to the conventional micro-
luidics due to its incapacity of analyzing samples at low concentrations31. Due to these constrains, and despite 
requiring more expensive equipment, conventional microluidics is chosen regularly for POC applications32.
his work describes in detail a novel and low-cost conventional Polydimethylsiloxane (PDMS) microlu-
idic chip which combines a short-path length micromixer and an optical circuit to perform colorimetric detec-
tion (Fig. 1). To demonstrate the impact of this microluidic chip for molecular diagnostics, gold-nanoprobe 
(Au-nanoprobe) assays were applied in the detection of BCR-ABL1 fusion transcript (RNA), which is the molec-
ular hallmark of chronic myeloid leukemia (CML).
CML is originated from the Philadelphia chromosome (Ph) - a reciprocal translocation of the long arms 
of chromosomes 9 and 22, t(9;22). his aberrant chromosome is found in more than 90% patients with CML, 
15–25% of patients with acute lymphoblastic leukemia (ALL) and 1% of newly diagnosed adults with acute mye-
loid leukemia33–35. he Philadelphia chromosome results from the fusion of two genes, BCR and ABL1. he chi-
meric gene leads to the translation of a constitutively active protein tyrosine kinase. Although several transcript 
isoforms have been reported, for the purpose of this study the Au-nanoprobe was designed towards the most 
frequent variant, e14a2, accounting for more than 55% of CML patients36,37. he high treatment success rate of the 
disease relies not only on drug eicacy, but also on fast, accurate and early diagnostic tools38. Due to the scarcity 
of such tools, intense research has been devoted to the development of new methodologies for CML screening 
and management.
Following design, fabrication and characterization of the chip, three case studies with increasing complexity 
were performed and analyzed in the present report: irst, Au-nanoprobes were used with and without salt to 
make the proof of concept; second, BCR-ABL1 synthetic oligonucleotides were combined with Au-nanoprobes 
to evaluate the mixing and cross-linking behavior under mixing and optical detection inside the microchannel; 
and third, the system performance was assessed using total RNA extracted from a CML cell line, which is the 
surrogate model for the disease, thus mimicking real clinical sample screening. hese results on-chip, obtained 
without requiring any ampliication steps, were faster than the standard laboratory operation process at macros-
cale7 and unprecedented at microscale even when compared with other similar and up to date methods39,40. hey 
have also provided a cheaper solution to methods that recur to luorescence41,42, and a simpler fabrication and 
cost eiciency when compared to other techniques43,44 without any signiicant losses in sensitivity. hese devices 
are suitable for the fast screenings required in medical care and POC, and key to unlock new and more complex 
versions of optical based genosensors, either to diagnose CML or other similar diseases.

ƪǤ he microluidic chip layout was conceived by combining 3 distinct sections 
(Fig. 2A). he irst section allowed infused solutions to reach the common channel simultaneously (Fig. 2A - i). 
his synchronization allows a more eicient utilization since no solution will be let unmixed.
he second component of the chip had a planar micromixer incorporated to perform mixing between solu-
tions (Fig. 2A - ii). his micromixer was chosen over active and 3D micromixers45,46 due to its cost eiciency and 
easy integration with other components of the microchannel, thus allowing low cost fabrication since it only 
requires a single layer of photolithography to yield the full design. Among passive planar micromixers, rhombic 
micromixers with obstacles47 are suitable for this application as they fulill the mixing requirements over a wide 
range of Reynold numbers and for short mixing channels (2.5 mm), and thus they were implemented in the 
described device. he integrated mixer has one and a half rhombi, and each edge has a total of nine diamond 
shaped obstacles to disturb the laminar low and force mixing between solutions (Fig. 2B). Each rhombus is also 
separated by throttles that seek to increase mixing eiciency even further by creating pressure gradients with an 
abrupt variation on the channel’s width. hese variations tend to generate vortexes, and thus, to enhance mixing.
he third and last section of the chip comprises the optical detection unit, where the nucleic acid colorimet-
ric analysis takes place (Fig. 2A - iii). his screening takes advantage of an extended optical path length design 
inside the chip13, which uses optical ibers to convey light between source and microluidic chip, and between 
microluidic chip and photodiode. Air lenses were incorporated at the entrance and exit, between the optical 
iber grooves and the detection channel, to minimize signal losses12; the former collimates light coming out of the 
iber tip and illuminates the microchannel content uniformly, and the latter focuses the outgoing light into the 
core of the output optical iber. Two optical grooves were also integrated in the chip design to enable approxima-
tion and alignment between optical ibers and channel (this is where the optical iber circuit crosses paths with 
the microluidic channel). Built-in cleaning channels were added to allow an easy removal of dust and particles 
before the optical iber insertion (Fig. 2C). Green (530 nm) and red (625 nm) light emitting diodes, detector and 
electrical setup were kept ixed, while disposable microluidic chips and attached optical ibers can be replaced 
with ease for a cleaner usage. LED wavelengths were chosen according to the absorption spectra of aggregated 
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and non-aggregated Au-nanoprobes48,49. he low price, biocompatibility and optical properties of PDMS made 
this silicon rubber a common choice to fabricate the microluidic chips by replica molding50,51. Full details on the 
chip design can be seen in Supplementary Information – Fig. S1.
Figure 1. Concept of this lab-on-chip as a POC application: (i) White cells extracted from a small blood sample 
are collected to analyze gene expression; (ii) his approach aims to diagnose chronic myeloid leukemia using 
its genetic marker, BCR-ABL1 fusion transcripts, present in the cells; (iii) Total RNA extracted is then mixed 
with Au-nanoprobes and heated to promote hybridization. Note that Au-nanoprobes are functionalized with 
BCR-ABL1 complementary sequences; (iv) he resulting solution and a salt solution are infused on the two 
microluidic chip inlets; (v) horough mixing and optical detection of these components is performed inside 
the microluidic chip. If the patient expresses BCR-ABL1 transcripts complementary to the oligonucleotide 
sequence of Au-nanoprobes, their hybridization will cause the inal solution to remain red (positive match) in 
the presence of salt. Otherwise, the non-hybridized Au-nanoprobes will aggregate and cause the inal solution 
to turn blue (negative match) in the presence of salt. Output results described in this step are displayed on the 
computer within 3 min.
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Ǥ An optoelectronic setup was assembled to integrate the microfabricated chips and to perform 
optical analysis. It included two wavelength light sources (625 nm LED; 530 nm LED) which emit light through an 
optical iber. his optical iber crosses the microluidic channel and interacts with the infused solution. A syringe 
pump was used to infuse solutions inside the chip. A photodetector transduced out coming light to a current 
signal, which was ampliied by an operation ampliier with a feedback network (capacitor: 1.5 nF; resistance: 
20 MΩ), and converted to a voltage signal. his analog signal was then converted to digital and acquired by the 
computer. Full details on the setup can be found in Supplementary Information – Fig. S2.
he detection response (Rs) was deined as the ratio of the digital output acquired by the computer of the red 
LED (dominant wavelength: 625 nm) and green LED (dominant wavelength: 530 nm) on a screened sample:
=R
Sample V nm
Sample V nm
Baseline V nm
Baseline V nm
(625 )
(530 )
/
(625 )
(530 ) (1)
s
out
out
out
out
his ratio was normalized to a baseline sample ratio, 10 mM phosphate bufer pH 8 solution, as it eliminates the 
intrinsic optical properties that vary from chip to chip or with time and usage12,13. Baseline data was extracted 
prior to and ater each assay in order to conirm the system reliability.
Ǥ Hybridization of Au-nanoprobes to targets was performed in 10 mM phosphate 
bufer pH 8, followed by a 5 min denaturation at 95 °C. Samples were then cooled down to room temperature 
Figure 2. (A) Microluidic chip design: (i) infusion section; (ii) mixing section; (iii) optical detection section; 1 – 
Target DNA/RNA and Au-nanoprobes solution inlet; 2 – Salt (MgCl2) inlet; 3 – Optical iber cleaning channel; 4 – 
Microchannel outlet; 5 – optical iber insertion cavity. (B) Detailed Scanning Electron Microscopy (SEM) picture of 
the mixing region. he mixing region takes advantage of 1.5 rhombi, each with 36 diamond shaped obstacles and 2 
throttles to perform eicient passive mixing. (C) Detailed SEM picture of the detection region. A collimating lens is 
used between the irst optical iber groove and microchannel to align the incoming light onto the channel. Likewise, 
two focusing lenses are used between microchannel and the second optical iber groove to focus the outcoming 
light onto the output optical iber.
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before injection into the chip. he microluidic chip was rinsed with isopropanol to increase the microchannel 
hydrophilicity and to avoid formation of bubbles that could otherwise afect optical readings and increase dead 
volume. A syringe pump was used to infuse two diferent solutions of 5 µL each, one in each inlet (lowrate: 5 µL/
min, Legato210P, KDScientiic, USA), according to each experiment and in a 1:1 proportion (Table 1). To attain 
immediate aggregation and maximize the output time, the optimum inal concentration of MgCl2 was found to 
be 0.2 M. his salt concentration was studied for the recommended inal concentration of Au-nanoprobes of 2.5 
nM7,52 (more details in Supplementary Information – Fig. S3). he input optical signal was generated by applying 
a current of 0.4 A to each LED, which was the value that ofered the best signal-to-noise ratio (SNR) ater inter-
polating experimental data with the Hermite method53 (more details in Supplementary Information – Fig. S4). 
Data acquisition of electrical output signals generated from LED transmitted light started immediately ater the 
micromixing of infused solutions, in a no low regime. hese measurements were acquired within 3 to 5 min ater 
mixing, with a sampling interval of approximately 1 minute. For baseline measurements, 10 mM phosphate bufer 
pH 8 solution was used as the transparent medium inside the chip. It was selected as a reliable baseline source as 
all the tested samples are diluted in this solution. his procedure normalizes the system response for the baseline 
(Rs = 1). Sample screenings with Rs > 1 mean that the output voltage was higher for red light, and correspond to 
non-aggregated results. Likewise, sample screenings with Rs ≈ 1 or Rs < 1 mean that the output voltage was simi-
lar or higher for green light which is the characteristic output of aggregated results.
Microchip sensitivity (∆Rs) was deined as the diference between the detection responses from assays with 
positive/non-aggregated results (Rs
+) and negative/aggregated results (Rs
−):
∆ = −+ −R R R (2)s s s
A one-way ANOVA analysis with Tukey’s Multiple Comparison test using Wolfram Mathematica 10.0 
(Champaign, IL) was used to validate the results. One-way analysis of variance was used.
Ǥ Au-nanoparticles of 14-nm in diameter were functionalized with the ssDNA probe that recog-
nizes a unique sequence on the BCR-ABL1 oncogene - the hallmark of CML, and fully characterized by UV visible 
spectroscopy, transmission electron microscopy (TEM) and dynamic light scattering (DLS) – see Supplementary 
Information – Table S5 and Fig. S5. he performance of the Au-nanoprobes used in this study had been previ-
ously thoroughly studied7. hey were able distinguish several BCR-ABL1 variants to a 100% accuracy and LOD 
was 15 ng/µL7. Here, LOD for RNA directly extracted from the cells without PCR ampliication was found at 40 
ng/µL despite its low SNR. No experimental outputs overlapping mismatch results were observed for 60 ng/µL of 
RNA – see Supplementary Information – Fig. S6.
he microluidic chip was used in conjunction with Au-nanoprobe assays to detect the speciic RNA sequence 
associated with CML in three progressive case studies (Table 1). he irst case study was performed to verify the 
colorimetric screening and reproducibility of hybridized Au-nanoprobes with/without salt (proof-of-concept). 
For the second case study, synthetic oligonucleotide sequences were added to Au-nanoprobes and mixed 
with salt to evaluate the output screening and reproducibility according to the tested sequence (complemen-
tary/non-complementary sequence of CML). This study was done as an intermediate step towards clinical 
trials. he only addition to Au-nanoprobes and salt is the synthetic oligonucleotide, either complementary or 
non-complementary. he complementary oligo sequences show a perfect match to the Au-nanoprobes, thus 
representing the best-case scenario of a positive match. To mimic clinical trials, the third case study uses RNA 
extracted from culture cells (K562, positive for BCR-ABL1/THP1, negative control) instead of synthetic DNA 
sequences, to evaluate the output screening and reproducibility of results. Due the complexity of RNA solutions, 
positive controls extracted from cells tend to have a lower ainity to Au-nanoprobes when compared to comple-
mentary synthetic oligonucleotide sequences but constitute a better comparison to the real clinical sample.
A discriminated response between complementary (POS) and non-complementary (NEG) assays was 
obtained for all 3 tested cases (Fig. 3). Performed statistical analysis of variance (ANOVA) with Tukey’s compar-
ison test output strongly suggested that positive and negative results belong to diferent populations (p <0.005), 
yielding a signiicant discrimination between POS and NEG.
For the irst case study, the Rs values obtained showed the least dependency on time. he absence of biolog-
ical targets and other impurities was a major contributor to this consistency (Fig. 3). he inclusion of synthetic 
1st case study 2nd case study 3rd case study
Inlet 1 Inlet 2 Inlet 1 Inlet 2 Inlet 1 Inlet 2
Positive trial [Au-nanoprobes]: 2.5 nM —
Hybridized [Au-
nanoprobes]:5 nM + [Target oligo]: 
200 nM (complementary)
[MgCl2]: 0.4 M
Hybridized [Au-
nanoprobes]: 5 nM + [Target 
RNA]: 120 ng/µL 
(complementary)
[MgCl2]: 0.4 M
ater mixing (1:1) 2.5 nM 2.5 nM + 100 nM + 0.2 M 2.5 nM + 60 ng/µL + 0.2 M
Negative trial [Au-nanoprobes]:5 nM [MgCl2]:0.4 M
Hybridized[Au-nanoprobes]: 
5 nM + [Target oligo]: 200 nM (non- 
complementary)
[MgCl2]:0.4 M
Hybridized[Au-
nanoprobes]: 5 nM + [Target 
RNA]: 120 ng/µL (non- 
complementary)
[MgCl2]:0.4 M
ater mixing (1:1) 2.5 nM + 0.2 M 2.5 nM + 100 nM + 0.2 M 2.5 nM + 60 ng/µL + 0.2 M
Table 1. Experimental conditions used in this work. Detailed description on the components used for each case 
study and respective concentrations.
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oligonucleotides and RNA, in the second and third case studies respectively, increased the inal solution density 
and added more variability, increasing the measurement errors. Positive measurements in these studies had Rs 
decrease over time. he presence of high salt concentration values may have promoted Au-nanoprobe aggrega-
tion and precipitation onto the microchannel over time, causing these losses in the ratio. Negative trials showed 
aggregation occurred sooner than 90 seconds, and thus, all the acquired data in these trials presented a stabiliza-
tion ratio of Rs ≈1.00. he Rs average values increased for the positive trials of the second and third case studies 
due to an increase in absorption of green light and decrease in absorption of red light, mainly caused by the 
non-aggregated Au-nanoprobes and respective targets. Experimental results showed that SNR decreases both 
with time and complexity of experiments, i.e. species in solution. he best SNR was attained between 90 and 
150 seconds, providing for the strongest outputs in the shortest frames of time (Fig. 4). he device’s SNRdB was 
calculated according to:
δ
=



∆
∆



SNR Log
R
R
10
(3)
dB
s
s
10
where ∆Rs and δ∆Rs are the device’s sensitivity and sensitivity error, respectively. Presence of target molecules 
(synthetic oligonucleotides and/or total RNA) appeared to induce an increase to the detection sensitivity, even 
though a slight increase to the noise was also perceived.
Time to data output was at least 10 times faster when to the of-chip Au-nanoprobe assay7 and 27 times 
faster when compared to conventional screening techniques for CML (RT-PCR)38,54 or to the few existent optical 
screenings with Au-nanoprobes at microscale12. he promotion of rapid kinetics of aggregation of Au-nanoprobes 
is enhanced by the proposed device, which greatly improves qualitative data output.

A novel multifunctional microchip was developed and used to detect BCR-ABL1, the fusion transcript respon-
sible for Chronic Myeloid Leukemia (CML), directly from total RNA extracted from cells, via colorimetric 
Au-nanoprobe non-cross-linking assay. he overall design and assembly was implemented taking into account 
ease of scale up production and maintaining low cost fabrication. hese characteristics make the device suitable 
Figure 3. Colorimetric results via proposed microluidic chip for each case study. Measurements were 
performed in 90–150 seconds (opaque bars) and 150–210 seconds (patterned bars) ater illing the detection 
chamber. Flow was at rest during data acquisition. Bars represent the average Rs of independent measurements 
(n ≥ 3) and error bars indicate standard deviations. Statistical analysis was performed with Mathematica 10.0, 
using one-way ANOVA and Tukey’s comparison test (p < 0.005).
Figure 4. Sensitivity between positive and negative colorimetric results, within 90–150 seconds (opaque bars) 
and 150–210 seconds (patterned bars), and signal-to-noise ratio trend over time (orange lines) for each case 
study. Bars represent the average ∆Rs of independent measurements (n ≥ 3) and the error bars indicate their 
standard deviations.
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for a disposable POC platform with a non-disposable host device integrating the two LED light sources, pho-
todetector and electronic circuit with signal ampliication, analogue to digital conversion and PC connectivity. 
Optimization of the mixing device made possible the detection of target RNA in a small sample volume (10 µL), 
thus reducing the amount of sample required (3 × less than conventional setups12).
Volume might be further reduced via addition of a non-miscible bufer (mineral oil) with the sole purpose of 
pushing the sample solution through the mixing and optical stages, as the colorimetric detection step requires 
only 50 nL (volume of the illed detection channel)55,56. he setup itself can also be optimized towards POC by 
miniaturizing its components, such as designing and incorporating a mechanical pump to the microluidic chip57 
and shortening its optical path length.
he gold standard for CML detection and follow-up is Quantitative Polymerase Chan Reaction (RT-qPCR), 
with a cost of €20 per sample. Based on current costs for Au-nanoprobe colorimetric assay, the estimated cost is 
€0.20–1.00 per assay7. A microluidic chip, integrating all steps for diagnostics, will depend on production setup 
that would bring costs of standalone chip operation to €10, but ofering unique advantages: the microluidic chip 
presented good sensitivity and was able to yield accurate results in a remarkably short period of time, due to the 
fast transition between mixing and detection stages provided by the chip’s design, and the process becomes avail-
able anywhere due to the possibility of portability. Moreover, the total cost of each assay can be further decreased 
with mass production of such devices.
Since the colorimetric method for CML screening has been fully validated in mimicked clinical samples, 
future work shall focus on the integration of this microluidic platform into a stand-alone device that will open 
the possibility to more complex, automatized and cost-efective generic DNA/RNA tests suitable for POC screen-
ing. In this speciic case, it will improve the early diagnosis of CML and provide an easy to use platform for follow 
up with patients.

Ǥ All chemicals were of molecular biology grade and purchased from Sigma-Aldrich. Ultrapure 
water used in these processes came from a Millipore water purification system (Merck Millipore, USA). 
Oligonucleotides were provided by STABVIDA, Portugal. SU-8 2050 photoresist, propylene glycolmethyl ether 
acetate developer (PGMEA) and customized masks, used during the lithography process of the microchip fab-
rication, were obtained from Microchem (Microchem, USA) and JDPhoto (JDPhoto-tools, UK), respectively. 
Epoxy resin ES562, used as a master mold for PDMS sot lithography, was ordered from Permabond (Permabond, 
UK). For the PDMS microchips fabrication, a Sylgard 184 Silicone Elastomer Kit was used (DowCorning, Spain). 
To improve separation between the PDMS and SU-8 mold, a silanization step was performed onto the SU-8 
mold using tridecaluoro-1,1,2,2-tetrahydrooctyl trichlorosilane (Microchem, USA). Microluidic connections 
between chip and reservoirs were made using an optimized Telon tubing kit, ordered from Elvelow (ElveSys 
SAS, France).
	ƪǤ Microluidic chips followed standard fabrication steps58,59. A mask 
with the chip’s pattern was designed in AutoCAD 2014 (AutoDesk, USA). his mask was then printed on sodal-
ime glass using chrome as ink for a precise deinition. he irst mold, on SU-8, was patterned by ultra-violet pho-
tolithography. SU-8 was spin-coated on silicon wafers at 1400 rpm (Karl Suss CT62/ Suss MicroTec, Germany) 
to form a layer with approximately 125 µm, sot baked on a levelled hotplate at 65 °C during 5 min, followed by 
25 min at 95 °C, then let for relaxation and cool down for 10 min. Aterwards, they were exposed on a mask 
aligner (MA6, SussMicroTec, Germany) for 18 s with an exposure dose of 310 mJ/cm2. he designed photolith-
ographic mask was used in this step, together with an i-line ilter to expose with the recommended wavelength 
of 365 nm. A post-bake took place for a duration of 5 min at 65 °C, followed by 11 min at 95 °C. he samples were 
then submerged to develop in PGMEA for approximately 12 min. A magnetic agitation at 500 rpm was used to 
enhance this process. In the end, samples were rinsed with isopropanol, and dried with compressed nitrogen.
A replica from the SU-8 mold was made using epoxy resin, which presents higher durability without losing 
the deinition required to fabricate several chips60,61. he SU-8 mold was irst silanized in a vacuum desiccator to 
facilitate the posterior removal of PDMS. PDMS was prepared by mixing base and curing agents in a 10:1 weight 
proportion, stirred, degassed in a vacuum desiccator and poured over the SU-8 mold for the curing process in 
a levelled oven for 4 hours at 65 °C. he PDMS slab fabricated in this process, with the complementary pattern, 
was subsequently peeled of from the SU-8 mold and placed on top of a Petri dish with features faced up. On top 
of the PDMS slab, epoxy resin was poured until a layer of approximately 2 mm in thickness was formed. Another 
degassing step took place in the vacuum desiccator to remove bubbles trapped in epoxy. To inish this process, 
epoxy was cured in the levelled oven at 120 °C for 1 hour and peeled from the PDMS. he resulting epoxy mold 
was then used for sot lithography fabrication of the PDMS chips. his procedure took the same steps as those 
described above for the PDMS slab.
For the inlets and outlet, PDMS chips were punched using a razor sharp stainless steel biopsy puncher with 
1.25 mm outer diameter. he chips were irreversibly bonded to glass slides, using oxygen plasma for 70 s at 98 
mTorr with an applied power of 100 W on a Trion Minilock Phantom III RIE (TrionTech, USA). To complete the 
plasma sealing, PDMS chips already bonded to glass were baked at 100 °C for 5 min to increase the bond strength.
Samples were characterized by optical microscopy (Leitz Laborlux12MEST, Leica, Germany), confocal scan-
ning microscopy (LSM700, CarlZeiss, Germany), proilometry (XP-200, Ambios Technology, Inc., SantaCruz, 
USA), UV-3101 PC UV/ visible/ NIR double beam spectrophotometry (Shimadzu, Japan) and scanning electron 
microscopy (SEM-FIB, ZeissAuriga, Germany).
Ǥ Two graded-index multimode optical ibers with 62.5 µm core diameter, 125 
µm cladding diameter and 0.275 numerical aperture (GIF625, horlabs, Germany) were stripped and cleaved 
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from both sides, and inserted in the input and output optical entrances of the chip. One of the two remaining 
iber tips was deined as the input iber and connected to a SMA-ended GIF625 patch cable (horlabs, Germany). 
his cable was either coupled to a high-power green LED (M530F1, dominant wavelength: 530 nm, half width: 
33 nm, typical output power: 5.1 mW, horlabs, Germany) or red LED (M625F1, dominant wavelength: 625 nm, 
half width: 18 nm, typical output power: 10.1 mW, horlabs, Germany). A constant current of 0.4 A was applied 
on both LEDs during the experiments. he other iber tip was deined as the output iber and was connected to a 
pigtailed silicon photodiode (FDSP625, horlabs, Germany). Connections with optical ibers were done with bare 
iber terminators (BFTU, horlabs, Germany) and mating sleeves.
A circuit with an operation ampliier (AD549, Analog Devices, USA) was used to enhance the photodiode 
output current, and convert it to a voltage signal. he photodiode was connected to the op-amp´s inverting 
input (virtual ground), and a feedback network that incorporated a capacitor (1.5 nF) and a resistor (20 MΩ). 
he op-amp’s noninverting input was grounded and the op-amp operation ranged from ± 12 V. Data acquisition 
as well as command sending were done via the computer using a LabView program (LabView 2013, National 
Instruments, USA) with a NI USB 6008 interface (National Instruments, USA). he same LabView program 
was used to operate a Legato 210 P syringe pump (KD Scientiic, USA), to automatically infuse and withdraw 
solutions from the chip.
ǦǤ Au-nanoprobe design and synthesis were performed as previously 
described7. he 14 nm AuNPs prepared by the citrate reduction method were functionalized with a thiolated 
oligonucleotide in 10 mM phosphate bufer (pH 8.0), 0.1 M NaCl. he resulting Au-nanoprobes were stored in the 
dark at 4 °C and characterized by UV visible spectroscopy, transmission electron microscopy (TEM) and dynamic 
light scattering (DLS).
he probe sequence and the complementary target were derived from the BCR-ABL1 e14a2 (also known as 
b3a2) chimeric protein mRNA (GeneBank Accession No AJ131466.1), which is the most frequent breakpoint 
in CML, accounting for 55% of cases54,62. Au-nanoprobe selectivity was assessed against two non-modiied syn-
thetic oligonucleotides: a complementary target corresponding to the BCR-ABL1 e14a2 mRNA sequence, and an 
unrelated sequence was used as non-complementary target (5′-AGA AGA GCT ACG AGC TGC CCG ATG GCC 
AGG TCA TCA CCAT-3′).
Immortalized human cell lines derived from a CML patient in blast crisis, K562 (BCR-ABL1 e14a2 fusion 
transcript positive cell line) and from an acute monocytic leukemia patient, THP1 (BCR-ABL1 negative) were 
cultured, respectively, in DMEM and RPMI with 10% (v/v) FBS, at 37 °C with 5% (v/v) CO2. hese cell lines were 
used as positive and negative controls for the presence and absence of BCR-ABL1 transcript, respectively.
Total RNA was extracted from K562 and THP1 cell pellets by the guanidine thiocyanate procedure (SV Total 
RNA Isolation System, Promega)7. RNA was resuspended in DEPC-treated water and stored at −80 °C until use. 
RNA concentration and purity was determined by UV spectrophotometry.
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